Return to Main Menu

ACS grant call for cancer research proposals Hollings Cancer Center (HCC) received an American Cancer Society Institutional Research Grant (ACS IRG) award of $240,000.         The ACS IRG is a block award to enable HCC to provide “seed money” grants (sub-awards) up to $20,000 per year to beginning investigators who have no national competitive research grant support.          The time period of the grant is July 1, 2003,  through Dec. 31, 2006. During the three-year period, the funds will go to a total of 12 beginning researchers as sub-awards by making sub-awards of $19,500 annually to four beginning researchers. The sub-awards will be for one-year cancer-related research projects.         In addition to the annual sub-awards, a student stipend of $2,500 will be made during the second and third years of the grant to an outstanding medical or graduate student in the professional health sciences to pursue cancer-related research while still enrolled in a formal program.       The principal investigator of the ACS IRG award is Carolyn Reed, M.D., director of HCC and the block award and the sub-awards will be managed through the Hollings Cancer Center. The award is exempt from indirect costs, so all funds are used for cancer research development.    During the ACS IRG grant period HCC will collaborate with the local ACS to promote ACS research opportunities and to disseminate information about research findings and benefits to public and professional groups. To learn more about the ACS IRG and other ACS research opportunities, visit the ACS Web site at http://www.cancer.org.    IRG sub-awards are intended to support independent, self-directed, early career investigators for whom the institution must provide research facilities or space customary for an independent investigator. Applicants for the individual awards should be within eight years of their first independent research or faculty appointment. Support of senior investigators, postdoctoral fellows, or junior investigators who have received prior support from the IRG is not permitted.       Recipients of the IRG sub-awards must be, at the time of the application, citizens or non-citizen nationals of the United States or its possessions and territories, or must have been lawfully admitted to the United States for permanent residence at the time of application.      IRG sub-awards are available to support applications from all health sciences, schools, colleges and departments within MUSC.        An ACS-IRG Review Committee consisting of funded investigators in cancer-related research will review and prioritize proposals for funding.    For more information, visit the Hollings Cancer Center's Web site at http://hcc.musc.edu.       Catalyst Online is published weekly, updated as needed and improved from time to time by the MUSC Office of Public Relations for the faculty, employees and students of the Medical University of South Carolina. Catalyst Online editor, Kim Draughn, can be reached at 792-4107 or by email, catalyst@musc.edu. Editorial copy can be submitted to Catalyst Online and to The Catalyst in print by fax, 792-6723, or by email to petersnd@musc.edu or catalyst@musc.edu. To place an ad in The Catalyst hardcopy, call Community Press at 849-1778.